May 5, 2011 – At the 2011 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition at the ExCel Centre in London, Elekta will demonstrate advanced solutions that provide clinicians with the tools to save and improve lives of cancer patients worldwide. This includes Elekta's new RFID system, Identify, which is designed to increase staff confidence in the integrity of patient identification and set up.

Identify harnesses precision radiofrequency identification technology and will ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify will feature complete integration with Elekta's Mosaiq Oncology Information System, enabling patient queuing, selection of patient details in monitoring of set-up position, optimizing workflow and enhancing safety. Identify will be a scalable solution – from the treatment room to the entire department – allowing centers to grow as needs change.

Throughout the five major solution areas at the Elekta booth, the company will demonstrate how its digital platforms offer robust upgrade paths to accommodate a wide range of clinical requirements. The solution areas are:
Secure Workflow – personalized efficiency
Stereotaxy – premium solutions for the most challenging cases
Delivery – clinically focused, digitally controlled
Imaging – inspiring clinical confidence
Quality Assurance – completing the picture

In addition, Elekta will host a lunch symposium titled Throughput with Confidence on Monday, May 9 at the Capital Suites. The symposium will feature presentations by notable experts in the field of radiation oncology:
Professor Frank Lohr, University Hospital, Mannheim, Germany: Efficient VMAT Planning and Delivery
Ben J. Mijnheer, Ph.D., NKI/AvL, Amsterdam, Netherlands: Experiences from AvL with EPID-based In-Vivo Dosimetry
PD Reinhart A. Sweeney, University Hospital, Wurzburg, Germany; Christian Hieronimi, Elekta: Identify - who, what, where and how. Now!

For more information: www.elekta.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now